Description: Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.
Home Page: www.hyundaibioscience.com
Academic Cooperation Building
Seoul,
South Korea
Phone:
82 70 7008 0114
Officers
| Name | Title |
|---|---|
| Jong-Won Choi | Joint Chief Exec. Officer |
| Ho-Suk Chon | Joint Chief Exec. Officer |
| Yeong-Jin Kim | Pres |
| Seok-Yong Choi | Chief Operating Officer and Sr. Managing Director |
| Beom-Chan Jeong | Sr. Managing Director |
| Chang-Hyoen Lee | Managing Director |
| Soon-Ho Hong | Managing Director |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Information Technology |
|---|---|
| GIC Group: | Technology Hardware & Equipment |
| GIC Industry: | Technology Hardware, Storage & Peripherals |
| GIC Sub-Industry: | Technology Hardware, Storage & Peripherals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 82.5439 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |